Buch, Englisch, 366 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 710 g
Buch, Englisch, 366 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 710 g
ISBN: 978-0-12-815213-3
Verlag: William Andrew Publishing
Zielgruppe
<p>Everyone interested in the strategy and practice of the preclinical phases of the creation of new medicines. Those wishing to understand the drivers of drug design or expand their knowledge of therapeutic target classes</p>
Fachgebiete
Weitere Infos & Material
1. Discovery and Development of Calcimimetic and Calcilytic Compounds Edward F. Nemeth, Bradford C. Van Wagenen and Manuel F. Balandrin 2. VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine) Nicole D. Harriott, John P. Williams, Evan B. Smith, Haig P. Bozigian and Dimitri E. Grigoriadis 3. Current Trends in Macrocyclic Drug Discovery and Beyond-Ro5 Sulejman Alihodzic, Mirjana Bukvic, Ivaylo J. Elenkov, Antun Hutinec, Sanja Kostrun, Dijana Pesic, Gordon Saxty, Linda Tomaskovic and Dinko Ziher 4. Recent Progress in the Discovery and Development of Small-Molecule Modulators of CFTR Phil R. Kym, Xueqing Wang, Mathieu Pizzonero and Steven E. Van der Plas 5. Big Data in Drug Discovery Nathan Brown, Jean Cambruzzi, Peter J. Cox, Mark Davies, James Dunbar, Dean Plumbley, Matthew A. Sellwood, Aaron Sim, Bryn I. Williams-Jones, Magdalena Zwierzyna and David W. Sheppard